Literature DB >> 18407562

Confidence intervals for ratios of AUCs in the case of serial sampling: a comparison of seven methods.

Thomas Jaki1, Martin J Wolfsegger, Meinhard Ploner.   

Abstract

Pharmacokinetic studies are commonly performed using the two-stage approach. The first stage involves estimation of pharmacokinetic parameters such as the area under the concentration versus time curve (AUC) for each analysis subject separately, and the second stage uses the individual parameter estimates for statistical inference. This two-stage approach is not applicable in sparse sampling situations where only one sample is available per analysis subject similar to that in non-clinical in vivo studies. In a serial sampling design, only one sample is taken from each analysis subject. A simulation study was carried out to assess coverage, power and type I error of seven methods to construct two-sided 90% confidence intervals for ratios of two AUCs assessed in a serial sampling design, which can be used to assess bioequivalence in this parameter.

Mesh:

Year:  2009        PMID: 18407562     DOI: 10.1002/pst.321

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  6 in total

1.  Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.

Authors:  Martin J Wolfsegger; Thomas Jaki
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-10-22       Impact factor: 2.745

2.  Assessment of pharmacologic area under the curve when baselines are variable.

Authors:  Jeremy D Scheff; Richard R Almon; Debra C Dubois; William J Jusko; Ioannis P Androulakis
Journal:  Pharm Res       Date:  2011-01-14       Impact factor: 4.200

3.  Bayesian approach to estimate AUC, partition coefficient and drug targeting index for studies with serial sacrifice design.

Authors:  Tianli Wang; Kyle Baron; Wei Zhong; Richard Brundage; William Elmquist
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

4.  Preferential Delivery of an Opioid Antagonist to the Fetal Brain in Pregnant Mice.

Authors:  John Oberdick; Yonghua Ling; Mitch A Phelps; Max S Yudovich; Karl Schilling; Wolfgang Sadee
Journal:  J Pharmacol Exp Ther       Date:  2016-05-05       Impact factor: 4.030

5.  Dose-response effects of oral guanidinoacetic acid on serum creatine, homocysteine and B vitamins levels.

Authors:  Sergej M Ostojic; Marko Stojanovic; Patrik Drid; Jay R Hoffman
Journal:  Eur J Nutr       Date:  2014-02-18       Impact factor: 5.614

6.  Creatine metabolism and safety profiles after six-week oral guanidinoacetic acid administration in healthy humans.

Authors:  Sergej M Ostojic; Barbara Niess; Marko Stojanovic; Milos Obrenovic
Journal:  Int J Med Sci       Date:  2013-01-03       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.